144 related articles for article (PubMed ID: 35261797)
1. Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1.
Hung YH; Lai MD; Hung WC; Chen LT
Am J Cancer Res; 2022; 12(2):713-728. PubMed ID: 35261797
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X; Zhang C; Tian Y
J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.
Yang J; Zeng Z; Qiao L; Jiang X; Ma J; Wang J; Ye S; Ma Q; Wei J; Wu M; Huang X; Ma D; Gao Q
Mol Cancer Res; 2019 Oct; 17(10):2015-2028. PubMed ID: 31308149
[TBL] [Abstract][Full Text] [Related]
4. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
Smeester BA; Slipek NJ; Pomeroy EJ; Bomberger HE; Shamsan GA; Peterson JJ; Crosby MR; Draper GM; Becklin KL; Rahrmann EP; McCarthy JB; Odde DJ; Wood DK; Largaespada DA; Moriarity BS
Oncogene; 2020 Jan; 39(5):1049-1062. PubMed ID: 31582836
[TBL] [Abstract][Full Text] [Related]
5. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
[TBL] [Abstract][Full Text] [Related]
7. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses.
Xue D; Desjardins M; Kaufman GN; Béland M; Al-Tamemi S; Ahmed E; Tao S; Friedel RH; Mourad W; Mazer BD
Front Immunol; 2016; 7():558. PubMed ID: 28003812
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin-4C is upregulated in epithelial ovarian cancer.
Huang S; Han S; Zhang J; Zhong Z; Wang J
Oncol Lett; 2020 Apr; 19(4):3333-3338. PubMed ID: 32256827
[TBL] [Abstract][Full Text] [Related]
10. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
[TBL] [Abstract][Full Text] [Related]
11. Sema4C modulates the migration of primary tumor-associated lymphatic endothelial cells via an ERK-mediated pathway.
Peng J; Liu X; Li C; Gao M; Wang H
Exp Ther Med; 2021 Oct; 22(4):1102. PubMed ID: 34504556
[TBL] [Abstract][Full Text] [Related]
12. Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells.
Zhou QD; Ning Y; Zeng R; Chen L; Kou P; Xu CO; Pei GC; Han M; Xu G
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):672-679. PubMed ID: 24142719
[TBL] [Abstract][Full Text] [Related]
13. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138+ Plasma Cells.
Xue D; Kaufman GN; Dembele M; Beland M; Massoud AH; Mindt BC; Fiter R; Fixman ED; Martin JG; Friedel RH; Divangahi M; Fritz JH; Mazer BD
J Immunol; 2017 Jan; 198(1):71-81. PubMed ID: 27881703
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C.
Wei JC; Yang J; Liu D; Wu MF; Qiao L; Wang JN; Ma QF; Zeng Z; Ye SM; Guo ES; Jiang XF; You LY; Chen Y; Zhou L; Huang XY; Zhu T; Meng L; Zhou JF; Feng ZH; Ma D; Gao QL
Clin Cancer Res; 2017 Jan; 23(1):214-224. PubMed ID: 27401250
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
17. Effect of microrna-138 on epithelial-Mesenchymal transition and invasion of breast cancer cells by targeting semaphorin 4C.
Liu H; Ye H; Li X
Bioengineered; 2021 Dec; 12(2):10117-10125. PubMed ID: 34747314
[TBL] [Abstract][Full Text] [Related]
18. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells.
Gurrapu S; Franzolin G; Fard D; Accardo M; Medico E; Sarotto I; Sapino A; Isella C; Tamagnone L
Sci Signal; 2019 Aug; 12(595):. PubMed ID: 31431542
[TBL] [Abstract][Full Text] [Related]
19. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
20. lncRNA CYTOR promotes cell proliferation and tumor growth via miR-125b/SEMA4C axis in hepatocellular carcinoma.
Tian Q; Yan X; Yang L; Liu Z; Yuan Z; Zhang Y
Oncol Lett; 2021 Nov; 22(5):796. PubMed ID: 34584571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
